Q4 2022 Earnings Estimate for Encompass Health Co. Issued By Jefferies Financial Group (NYSE:EHC)

Posted by MarketBeat News on Aug 5th, 2022

Encompass Health Co. (NYSE:EHC – Get Rating) – Jefferies Financial Group decreased their Q4 2022 earnings estimates for Encompass Health in a research note issued to investors on Wednesday, August 3rd. Jefferies Financial Group analyst B. Tanquilut now anticipates that the company will earn $0.88 per share for the quarter, down from their previous forecast of $1.05. The consensus estimate for Encompass Health’s current full-year earnings is $2.84 per share.

Encompass Health (NYSE:EHC – Get Rating) last issued its earnings results on Monday, August 1st. The company reported $0.89 EPS for the quarter, missing the consensus estimate of $0.97 by ($0.08). Encompass Health had a net margin of 6.22% and a return on equity of 16.20%. The firm had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.34 billion. During the same period in the previous year, the company posted $1.17 EPS. The firm’s revenue for the quarter was up 3.3% on a year-over-year basis.

Several other equities research analysts also recently commented on EHC. Truist Financial lowered their target price on shares of Encompass Health from $85.00 to $75.00 and set a “buy” rating for the company in a research note on Tuesday, June 21st. Royal Bank of Canada lowered their price objective on shares of Encompass Health from $85.00 to $82.00 in a research report on Wednesday, June 8th. StockNews.com downgraded shares of Encompass Health from a “buy” rating to a “hold” rating in a research report on Wednesday. TheStreet downgraded shares of Encompass Health from a “b-” rating to a “c+” rating in a research report on Tuesday, June 28th. Finally, Raymond James lowered their price objective on shares of Encompass Health from $70.00 to $65.00 and set a “strong-buy” rating for the company in a research report on Thursday. One research analyst has rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $74.60.

Encompass Health Stock Down 0.9 %

Shares of NYSE:EHC opened at $52.87 on Thursday. Encompass Health has a 52 week low of $44.33 and a 52 week high of $83.43. The company has a debt-to-equity ratio of 1.29, a quick ratio of 1.26 and a current ratio of 1.24. The company has a market capitalization of $5.28 billion, a PE ratio of 16.17, a PEG ratio of 2.45 and a beta of 0.91. The company has a 50 day moving average price of $54.36 and a two-hundred day moving average price of $62.88.

Encompass Health Cuts Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, October 17th. Investors of record on Monday, October 3rd will be given a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date of this dividend is Friday, September 30th. Encompass Health’s dividend payout ratio (DPR) is currently 34.25%.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the business. Personal Capital Advisors Corp lifted its stake in Encompass Health by 4.7% in the second quarter. Personal Capital Advisors Corp now owns 706,213 shares of the company’s stock valued at $39,583,000 after acquiring an additional 31,900 shares during the last quarter. State of New Jersey Common Pension Fund D lifted its stake in Encompass Health by 7.4% in the second quarter. State of New Jersey Common Pension Fund D now owns 55,617 shares of the company’s stock valued at $3,117,000 after acquiring an additional 3,818 shares during the last quarter. TD Asset Management Inc. lifted its stake in Encompass Health by 142.9% in the second quarter. TD Asset Management Inc. now owns 338,629 shares of the company’s stock valued at $18,980,000 after acquiring an additional 199,222 shares during the last quarter. Envestnet Asset Management Inc. lifted its stake in Encompass Health by 2.0% in the second quarter. Envestnet Asset Management Inc. now owns 150,766 shares of the company’s stock valued at $8,451,000 after acquiring an additional 3,006 shares during the last quarter. Finally, Retirement Systems of Alabama lifted its stake in Encompass Health by 0.3% in the second quarter. Retirement Systems of Alabama now owns 271,374 shares of the company’s stock valued at $15,211,000 after acquiring an additional 930 shares during the last quarter. Institutional investors own 91.70% of the company’s stock.

Encompass Health Company Profile

(Get Rating)

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.